Investigation on the Relationship between D-Dimer and Cell Blood Count Indices in COVID-19 Prognosis: A Retrospective Study on 320 COVID-19 Patients

Document Type : Original Article


1 Department of Internal Medicine, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

2 Bachelor of Science, Ferdowsi University of Mashhad, Mashhad, Iran.


Due to the spreading of coronavirus infection in 2019 (COVID-19) throughout the world, tracking cell blood count (CBC) of moderate to severe COVID-19 patients could provide new insights for the prognosis prediction.
Materials and Methods:
In this observational-retrospective study, D-dimer and CBC documents of 320 confirmed COVID-19 patients hospitalized in Shamsoshomus Clinic, Mashhad, Iran, were evaluated. Receiver operation characteristics (ROC) curve was analysed to determine specificity and sensitivity of D-dimer and hematological indices, including white blood cell (WBCs), lymphocytes, monocytes, eosinophil, red blood cell width (RDW), platelets (PLT), and mean of platelet volume (MPV). 
This study included 157 (49.1%) male and 163 (50.3%) female COVID-19 patients between 14 to 96 years old. According to their status in the duration of hospitalization, patients were considered in the good outcome group (N=215) and poor outcome group (N=105). A significant difference was observed in D-dimer, WBCS, PMN, Lymph, monocytes, eosinophil, and RDW between the two groups (P<0.001). The highest sensitivity and the lowest specificity belonged to RDW (99%, 4%), WBCs (98%, 4%), PMN (99%, 11%) and D-dimer (96%, 42%). D-dimer indicated a significant association with WBCs, PMN, and RDW (P<0.05).
The present study revealed that WBCs and RDW might be recommended for the COVID-19 prognosis prediction due to their high comparable sensitivity to D-dimer.


Main Subjects

  1. Zhan H, Chen H, Liu C, Cheng L, Yan S, Li H, et al. Diagnostic value of D-Dimer in COVID-19: a meta-analysis and meta-regression. Clinical and Applied Thrombosis/Hemostasis. 2021;27:10760296211010976.
  2. Bikdeli B, Madhavan MV, Jimenez D, Chuich T, Dreyfus I, Driggin E, et al. COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up: JACC state-of-the-art review. Journal of the American college of cardiology. 2020;75(23):2950-73.
  3. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. The lancet. 2020;395(10223):507-13.
  4. Guan W-j, Ni Z-y, Hu Y, Liang W-h, Ou C-q, He J-x, et al. Clinical characteristics of coronavirus disease 2019 in China. New England journal of medicine. 2020;382(18):1708-20.
  5. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The lancet. 2020;395(10229):1054-62.
  6. Kaftan AN, Hussain MK, Algenabi AA, Naser FH, Enaya MA. Predictive Value of C–reactive Protein, Lactate Dehydrogenase, Ferritin and D-dimer Levels in Diagnosing COVID-19 Patients: a Retrospective Study. Acta Informatica Medica. 2021;29(1):45.
  7. Lu G, Wang J. Dynamic changes in routine blood parameters of a severe COVID-19 case. Clinica Chimica Acta. 2020;508:98-102.
  8. Yang M, Li CK, Li K, Hon KLE, Ng MH, Chan PK, et al. Hematological findings in SARS patients and possible mechanisms. International journal of molecular medicine. 2004;14(2):311-5.
  9. Qin C, Zhou L, Hu Z, Zhang S, Yang S, Tao Y, et al. Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in Wuhan, China. Clinical infectious diseases. 2020; 71(15):762-8.
  10. Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive care medicine. 2020; 46(5):846-8.
  11. Bizzarro MJ, Conrad SA, Kaufman DA, Rycus P. Infections acquired during extracorporeal membrane oxygenation in neonates, children, and adults. Pediatric Critical Care Medicine. 2011; 12(3):277-81.
  12. Sharma D, Dayama A, Banerjee S, Bhandhari S, Chatterjee A, Chatterjee D. To Study the Role of Absolute Lymphocyte Count and RDW in COVID 19 Patients and their Association with Appearance of Symptoms and Severity. The Journal of the Association of Physicians of India. 2020;68(8):39-42.
  13. Gong J, Ou J, Qiu X, Jie Y, Chen Y, Yuan L, et al. A tool to early predict severe 2019-novel coronavirus pneumonia (COVID-19): a multicenter study using the risk nomogram in Wuhan and Guangdong. China[PMC free article][PubMed][Google Scholar]. 2017.
  14. Qu R, Ling Y, Zhang Yhz, Wei Ly, Chen X, Li Xm, et al. Platelet‐to‐lymphocyte ratio is associated with prognosis in patients with coronavirus disease‐19. Journal of medical virology. 2020;92(9):1533-41.
  15. China NHCotPsRo. Chinese management guideline for COVID-19 (version 6.0). 2020.
  16. Llitjos JF, Leclerc M, Chochois C, Monsallier JM, Ramakers M, Auvray M, et al. High incidence of venous thromboembolic events in anticoagulated severe COVID‐19 patients. Journal of Thrombosis and Haemostasis. 2020; 18(7):1743-6.
  17. Rocha AT, Paiva EF, Lichtenstein A, Milani Jr R, Cavalheiro-Filho C, Maffei FH. Risk-assessment algorithm and recommendations for venous thromboembolism prophylaxis in medical patients. Vascular health and risk management. 2007;3(4):533.
  18. Spies C. Innate immunity recovers earlier than acquired immunity during severe postoperative immunosuppression. Inter- national Journal of medical sciences. 2018; 15(1):1.
  19. Foy BH, Carlson JC, Reinertsen E, Valls RP, Lopez RP, Palanques-Tost E, et al. Elevated RDW is associated with increased mortality risk in COVID-19. medRxiv. 2020.
  20. Terpos E, Ntanasis‐Stathopoulos I, Elalamy I, Kastritis E, Sergentanis TN, Politou M, et al. Hematological findings and complications of COVID‐19. American journal of hematology. 2020; 95(7):834-47.
  21. Henry BM, Benoit JL, Benoit S, Pulvino C, Berger BA, Olivera MHSd, et al. Red blood cell distribution width (RDW) Predicts COVID-19 severity: a prospective, observational study from the cincinnati SARS-CoV-2 emergency department cohort. Diagnostics. 2020;10(9):618.
  22. Pafili K, Penlioglou T, Mikhailidis DP, Papanas N. Mean platelet volume and coronary artery disease. Current opinion in cardiology. 2019;34(4):390-8.
  23. Ha S-I, Choi D-H, Ki Y-J, Yang J-S, Park G, Chung J-W, et al. Stroke prediction using mean platelet volume in patients with atrial fibrillation. Platelets. 2011;22(6):408-14.
  24. Turfan M, Erdogan E, Ertas G, Duran M, Murat SN, Celik E, et al. Usefulness of mean platelet volume for predicting stroke risk in atrial fibrillation patients. Blood Coagulation & Fibrinolysis. 2013;24(1):55-8.
  25. Günay E, Sarinc Ulasli S, Kacar E, Halici B, Unlu E, Tünay K, et al. Can platelet indices predict obstruction level of pulmonary vascular bed in patients with acute pulmonary embolism? The clinical respiratory journal. 2014;8(1):33-40.
  26. Hilal E, Neslihan Y, Gazi G, Sinan T, Zeynep Ayfer A. Does the mean platelet volume have any importance in patients with acute pulmonary embolism? Wiener klinische Wochenschrift. 2013;125(13):381-5.
  27. Tapson VF. Advances in the diagnosis and treatment of acute pulmonary embolism. F1000 medicine reports. 2012;4.
  28. Bauvois B, Mothu N, Nguyen J, Nguyen-Khoa T, Nöel L-H, Jungers P. Specific changes in plasma concentrations of matrix metalloproteinase-2 and-9, TIMP-1 and TGF-β1 in patients with distinct types of primary glomerulonephritis. Nephrology Dialysis Transplantation. 2007; 22(4): 1115-22.
  29. Jackson S, Carter J. Platelet volume: laboratory measurement and clinical application. Blood reviews. 1993;7(2):104-13.
  30. Takano T, Matsumura T, Adachi Y, Terahara K, Moriyama S, Onodera T, et al. Myeloid cell dynamics correlating with clinical outcomes of severe COVID-19 in Japan. International immunology. 2021;33(4):241-7.